Octaplas Solution
Product Images NDC 68982-953

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Octaplas (NDC 68982-953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

This appears to be a chart or table showing production data for virus reduction. It looks like there are several steps involved, and the table shows the virus reduction factor achieved (in logy units) for each step. The data includes treatment numbers and a "global reduction factor." Without more context or information, it's difficult to determine the purpose or significance of this data.*

FDA Label Image

Image File (Img0002)

The text describes a product called Ocraplas Pooled Plasma (Human), which is treated with Solvent/Detergent and is used intravenously only. It contains sodium citrate dihydrate, sodium dihydrogen phosphate dihydrate, glycine, TNBP, and Octoxynol with no preservatives. It should be stored at <-18°C (-0.4°F), and the thawed product should be used immediately and not refrozen. It also provides information on the manufacturing of Octaplas™ Blood group 8,200mL | Octaplas™ Blood group B, 200 mL. The lot number and expiration date are also given.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.